Solitek brings a new concept in solid state development: crystallization, polymorphism, cocrystals, salt selection, preformulation and solubility studies. Combining an excellent understanding of the diversity of the solid form landscape exhibited by small molecule organic compounds with experience and practical know-how, Solitek can increase your chances of success, while reducing the overall cost of development. Solitek offers the advice you need, relevant to your requirements, to help reduce the risk of failure during the later development stages and to maximise the returns from potential out-licensing opportunities. Solitek promotes collaboration over competition and believes in the synergy of two teams working together towards a common goal.
| Website | http://www.solitekpharma.com |
| Employees | 8 (6 on RocketReach) |
| Founded | 2021 |
| Industry | Research |
| Keywords | Drug Development, Pharmaceutical Research, Pharmaceutical Development, Medicinal Chemistry, Solid State Chemistry, Drug Product Development, Drug Formulation, Crystallization, Crystal Engineering, Materials Science, Process Chemistry, Analytical Chemistry |
| Competitors | Pfizer, Amgen, Bristol Myers Squibb, Teva Pharmaceuticals, Novartis, Fresenius Kabi, Sandoz, Solvay, GSK, Merck AH +40 more (view full list) |
Looking for a particular Solitek - Solid Technologies SL employee's phone or email?
Victor Perez is the Co-Founder and Operations Director of Solitek - Solid Technologies SL.
6 people are employed at Solitek - Solid Technologies SL.